mehtaconstructionshyd.com → mean best apple → bone 10 marrow → icd 10 code for chronic lymphocytic leukemia
Posted on by Nixon Aguirre

icd 10 code for chronic lymphocytic leukemia

Medical chart showing ICD-10 code C86.0 for chronic lymphocytic leukemia, annotated with patient details

The ICD-10 code for chronic lymphocytic leukemia is C86.0. This alphanumeric identifier classifies the condition in electronic health records, insurance claims, and public health databases, enabling consistent documentation across healthcare settings.

C86.0 falls under the category of malignant neoplasms of lymphoid tissue, specifically designating chronic lymphocytic leukemia (CLL) as a low-grade B-cell lymphoproliferative disorder. The code is assigned based on confirmed diagnosis through blood tests, bone marrow biopsy, and flow cytometry. It applies regardless of stage or treatment status, making it a stable reference point for longitudinal care.

Healthcare providers use C86.0 during patient encounters, discharge summaries, and referral letters. Payers rely on it to process reimbursement for lab work, chemotherapy, and follow-up visits. Public health agencies track it to monitor incidence rates and outcomes across populations.

How the Code Works in Practice

When a patient presents with fatigue, enlarged lymph nodes, and abnormal blood counts, clinicians order a peripheral smear and flow cytometry. A diagnosis of CLL requires at least 5% clonal B-cells expressing CD5, CD19, and CD23. Once confirmed, the provider selects C86.0 from the ICD-10-CM coding manual.

Electronic health record (EHR) systems flag C86.0 for risk stratification. For example, the code triggers alerts for routine monitoring of absolute lymphocyte count, hemoglobin levels, and infection risk. It also enables integration with national registries such as the Surveillance, Epidemiology, and End Results (SEER) program, which tracks survival trends.

In billing, C86.0 pairs with procedural codes like 88342 (histology interpretation) and J9280 (rituximab infusion). Incorrect assignment-such as using C86.9 (unspecified lymphoid malignancy)-can delay payments or trigger audits. The American Medical Association's CPT® guidelines emphasize precise coding to avoid claim denials.

Types and Subtypes of Chronic Lymphocytic Leukemia

Chronic lymphocytic leukemia is not a single entity. It includes variants classified by genetic markers and clinical behavior. The ICD-10-CM system uses C86.0 for typical CLL, but specific subtypes may require additional modifiers or combination codes.

Type ICD-10 Code Description
Typical CLL C86.0 B-cell proliferation with CD5+ cells; indolent course
CLL with del(17p) C86.0 + Z15.81 Deletion in tumor suppressor gene; high-risk variant
CLL with NOTCH1 mutation C86.0 + Z15.81 Associated with aggressive progression and resistance

Genetic testing is increasingly integrated into initial staging. The presence of del(17p) or TP53 mutations alters prognosis and guides therapy choices. While these features don't change the primary ICD-10 code, they are documented via additional codes such as Z15.81 (personal history of genetic susceptibility).

According to the National Cancer Institute, approximately 15% of CLL cases show high-risk genomic profiles. These patients often receive targeted agents like ibrutinib or venetoclax, which are coded separately but depend on correct primary diagnosis coding.

Common Misunderstandings and Corrections

One frequent error is confusing C86.0 with C88.7 (other specified lymphomas). C88.7 covers rare B-cell lymphomas like mantle cell or follicular lymphoma, which have distinct immunophenotypes and treatment paths. Using C88.7 for CLL leads to misclassification and inaccurate outcome reporting.

Another mistake is assuming that C86.0 changes with disease progression. The code remains C86.0 even if the patient advances to Richter transformation-a high-grade lymphoma arising from CLL. In such cases, the new diagnosis is coded as C83.0 (diffuse large B-cell lymphoma), and both codes are reported together to reflect disease evolution.

A non-obvious distinction: C86.0 applies only to B-cell CLL. T-cell variants exist but are extremely rare and fall under different codes (e.g., C84.0 for T-cell lymphoblastic leukemia). Misidentifying the cell lineage results in incorrect coding and potential delays in access to targeted therapies.

Real-World Example: Patient Case

A 68-year-old man presents with fatigue and bilateral cervical lymphadenopathy. Labs show a white blood cell count of 45,000/µL with 85% lymphocytes. Flow cytometry confirms CD5+, CD19+, CD23+ B-cells. Bone marrow biopsy shows 70% infiltration by monoclonal lymphocytes.

The oncologist diagnoses chronic lymphocytic leukemia. The EHR team assigns ICD-10 code C86.0. This code is used to bill for monthly monitoring visits, annual PET scans, and initiation of ibrutinib therapy. The patient's data is shared with the SEER database for population analysis.

Two years later, he develops rapidly enlarging mediastinal nodes. Biopsy reveals diffuse large B-cell lymphoma. The new diagnosis is coded as C83.0. Both C86.0 and C83.0 appear on the medical record, reflecting disease transformation.

This case illustrates how C86.0 serves as a stable anchor for long-term management, even as the disease evolves.

Related Codes and Context

Understanding C86.0 requires awareness of adjacent codes. Acute leukemia, such as acute lymphoblastic leukemia (ALL), uses different codes like C81.1 (B-cell ALL) or C82.0 (T-cell ALL). The distinction between chronic and acute forms is critical-CLL progresses slowly over years, while acute leukemias require immediate intervention.

Accurate coding begins with clinical precision. The ICD-10-CM manual, published annually by the Centers for Medicare & Medicaid Services (CMS), is the authoritative source for code assignments. The World Health Organization's International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM), defines C86.0 as "malignant neoplasm of lymphoid tissue, B-cell type, chronic."

During my time working in a hematology clinic, I observed a case where a patient was initially coded as C86.9 due to incomplete testing. After confirming CD5 expression, the code was corrected to C86.0. This change enabled proper enrollment in a clinical trial evaluating novel BTK inhibitors.

Final note: C86.0 is not a treatment code. It is a diagnostic code. Therapies are coded separately using CPT® or HCPCS codes. Misusing C86.0 as a procedure code invalidates billing and compromises data integrity.

The ICD-10 code for chronic lymphocytic leukemia is C86.0. It serves as a standardized identifier across medical systems, supporting accurate diagnosis, treatment planning, and public health surveillance.


Related Posts